Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Advanced Medicine discloses new nicotinic acetylcholine receptor modulators and use as analgesics

Oct. 3, 2001

ORP150: therapeutic potential in stroke

Oct. 3, 2001

CNS excitability reduced by rhubarb extracts in rat hippocampal neurons

Oct. 3, 2001

NBI-34060 to move to phase III following positive phase II results

Oct. 3, 2001

Sepracor initiates clinical testing of new compound for anxiety

Oct. 3, 2001

GRT-1539R representative of a new series of glycine-site NMDA antagonists

Oct. 2, 2001

AMPA antagonists designed by ADIR lack nephrotoxicity

Oct. 2, 2001

Potential antidepressant with neuroprotective properties identified at CV Technologies

Oct. 2, 2001

Boehringer Ingelheim presents new AMPA receptor modulators and potential uses thereof

Oct. 1, 2001

Nastech licenses European rights to intranasal morphine

Oct. 1, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026